Diaryl-substituted tetrahydroisoquinolines as histamine H3 receptor and serotonin transporter modulators
US7846930B2 · kind B2 · utility
20Cited by
1References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 13, 2008 |
| Grant date | Dec 7, 2010 |
| Priority date | — |
| Expiry date | Mar 6, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Certain diaryl-substituted tetrahydroisoquinoline compounds are histamine H3 receptor and/or serotonin transporter modulators useful in the treatment of histamine H3 receptor- and/or serotonin-mediated diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.